OUR PROGRESS
From world-leading research to a VC-backed solution to detect the onset of vascular disease.
3 YEARS AGO
Exploratory research.
Our founders’ world-leading research demonstrated a successful proof of concept for early detection of vascular disease.
2 YEARS AGO
World-class backing.
Backed by Australia’s leading VC, Blackbird Ventures, we began partnering with pre-eminent surgeons, imaging labs, and dialysis providers.
LAST YEAR
First prototype.
We completed the first prototype build of our ultrasound imaging robot, with initial human testing.
NOW
Clinical trials.
We’re growing fast, conducting clinical trials and soon will be seeking regulatory clearances
Learn about the world-leading research that inspired Vexev.
Our founders met while completing their PhDs at the University of New South Wales.
Eamonn, a physicist, and John, a biomedical engineer, modelled real patient blood flows to detect the onset of vascular disease. Together they developed the tech to scan patients with a custom system, as well as automating the construction of flow models for every single scan.
Together, they captured vascular disease progression within real patients’ vessels, allowing for before and after models to be created for the first time, as well as building the largest dataset of realistic flow models.
While Vexev’s tech has developed a long way since then and been rebuilt for purpose, you can read their original published research and theses below:
Eamonn’s Publications and PhD
John’s Publications and PhD